ribavirin has been researched along with Autoimmune Demyelinating Disease, Peripheral in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abravanel, F; Belliere, J; Cintas, P; Cointault, O; Faguer, S; Izopet, J; Kamar, N; Lavayssière, L; Lhomme, S; Martinez, S; Nogier, MB | 1 |
Attarian, S; Borentain, P; Colson, P; Gérolami, R; Sevy, A; Sicello, M | 1 |
Ishida, C; Kato-Motozaki, Y; Komai, K; Kusunoki, S; Takahashi, K; Ueda, M; Yamada, M | 1 |
Conceição, I; Couto, M; de Carvalho, M | 1 |
4 other study(ies) available for ribavirin and Autoimmune Demyelinating Disease, Peripheral
Article | Year |
---|---|
Transfusion-acquired hepatitis E infection misdiagnosed as severe critical illness polyneuromyopathy in a heart transplant patient.
Topics: Antiviral Agents; Blood Transfusion; Critical Illness; Diagnostic Errors; Fatal Outcome; Heart Transplantation; Hepatitis E; Hepatitis E virus; Humans; Male; Middle Aged; Multiple Organ Failure; Muscular Diseases; Polyneuropathies; Polyradiculoneuropathy; Postoperative Period; Ribavirin; RNA, Viral | 2017 |
Evolution of hepatitis E virus-associated meningo-polyradiculoneuropathy on ribavirin.
Topics: Antiviral Agents; Cerebrospinal Fluid; Hepatitis E; Hepatitis E virus; Humans; Male; Meningitis; Middle Aged; Polyradiculoneuropathy; Ribavirin; RNA, Viral; Serum; Treatment Outcome | 2016 |
Polyethylene glycol interferon alpha-2b-induced immune-mediated polyradiculoneuropathy.
Topics: Antiviral Agents; Autoantibodies; Autoantigens; Autoimmune Diseases of the Nervous System; Drug Carriers; Drug Therapy, Combination; G(M1) Ganglioside; Gait Disorders, Neurologic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Muscle Weakness; Plasmapheresis; Polyethylene Glycols; Polyradiculoneuropathy; Recombinant Proteins; Ribavirin | 2009 |
Steroid-responsive demyelinating motor neuropathy with conduction block associated with hepatitis C infection and treatment with interferon alpha.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Demyelinating Diseases; Evoked Potentials, Somatosensory; Female; Hepatitis C; Humans; Interferon-alpha; Methylprednisolone; Middle Aged; Neural Conduction; Neuroprotective Agents; Polyradiculoneuropathy; Prednisone; Ribavirin | 2006 |